Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal. Orion Biotech Opportunities Corp. closed its initial public offering (IPO) of 20,000,000 units at a price of...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Wilton Re on the deal. Wilton Re, a leading provider of in-force and reinsurance solutions in the North American life insurance industry,...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised MSD Acquisition Corp. on the deal. MSD Acquisition Corp., a special purpose acquisition company, copleted its initial public offering of 57,500,000 units...
You must be a Standard 1 Year member to access this content.
